Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2005 1
2006 2
2007 4
2008 4
2009 6
2010 4
2011 8
2012 6
2013 1
2014 5
2015 5
2016 9
2017 6
2018 5
2019 23
2020 30
2021 23
2022 8
Text availability
Article attribute
Article type
Publication date

Search Results

136 results
Results by year
Filters applied: . Clear all
Page 1
Progress and Control of Myopia by Light Environments.
Jiang X, Kurihara T, Torii H, Tsubota K. Jiang X, et al. Among authors: kurihara t. Eye Contact Lens. 2018 Sep;44(5):273-278. doi: 10.1097/ICL.0000000000000548. Eye Contact Lens. 2018. PMID: 30048342 Review.
Violet light suppresses lens-induced myopia via neuropsin (OPN5) in mice.
Jiang X, Pardue MT, Mori K, Ikeda SI, Torii H, D'Souza S, Lang RA, Kurihara T, Tsubota K. Jiang X, et al. Among authors: kurihara t. Proc Natl Acad Sci U S A. 2021 Jun 1;118(22):e2018840118. doi: 10.1073/pnas.2018840118. Proc Natl Acad Sci U S A. 2021. PMID: 34031241 Free PMC article.
Violet Light Exposure Can Be a Preventive Strategy Against Myopia Progression.
Torii H, Kurihara T, Seko Y, Negishi K, Ohnuma K, Inaba T, Kawashima M, Jiang X, Kondo S, Miyauchi M, Miwa Y, Katada Y, Mori K, Kato K, Tsubota K, Goto H, Oda M, Hatori M, Tsubota K. Torii H, et al. Among authors: kurihara t. EBioMedicine. 2017 Feb;15:210-219. doi: 10.1016/j.ebiom.2016.12.007. Epub 2016 Dec 16. EBioMedicine. 2017. PMID: 28063778 Free PMC article.
Efficacy and safety of 0.01% atropine for prevention of childhood myopia in a 2-year randomized placebo-controlled study.
Hieda O, Hiraoka T, Fujikado T, Ishiko S, Hasebe S, Torii H, Takahashi H, Nakamura Y, Sotozono C, Oshika T, Morimoto T, Nishida K, Nishikawa N, Song YS, Tokutake T, Nishi Y, Shigeno Y, Kurihara T, Negishi K, Tsubota K, Ono M, Nakai T, Tan D, Tanaka S, Kinoshita S; ATOM-J. Study Group. Hieda O, et al. Among authors: kurihara t. Jpn J Ophthalmol. 2021 May;65(3):315-325. doi: 10.1007/s10384-021-00822-y. Epub 2021 Feb 14. Jpn J Ophthalmol. 2021. PMID: 33586090 Clinical Trial.
Reply.
Suzuki M, Nagai N, Shinoda H, Uchida A, Kurihara T, Tomita Y, Kamoshita M, Iyama C, Tsubota K, Ozawa Y. Suzuki M, et al. Among authors: kurihara t. Am J Ophthalmol. 2016 Sep;169:295-296. doi: 10.1016/j.ajo.2016.06.018. Epub 2016 Jul 15. Am J Ophthalmol. 2016. PMID: 27427198 No abstract available.
PPARα Agonist Oral Therapy in Diabetic Retinopathy.
Tomita Y, Lee D, Tsubota K, Kurihara T. Tomita Y, et al. Among authors: kurihara t. Biomedicines. 2020 Oct 19;8(10):433. doi: 10.3390/biomedicines8100433. Biomedicines. 2020. PMID: 33086679 Free PMC article. Review.
Long-term follow-up of a Chinese patient with KCNV2-retinopathy.
Lie H, Wang G, Liu X, Meng X, Long Y, Ren J, Yang L, Fujinami-Yokokawa Y, Kurihara T, Tsubota K, Fujinami K, Li S. Lie H, et al. Among authors: kurihara t. Ophthalmic Genet. 2021 Apr;42(2):144-149. doi: 10.1080/13816810.2020.1861307. Epub 2020 Dec 29. Ophthalmic Genet. 2021. PMID: 33372566
136 results